Loading the section…
The price of Lifevantage Corporation (LFVN) on October 9, 2026 is 6.00 USD, +0.17% on the day. Over 52 weeks the stock traded between 3.90 USD and 11.71 USD; the price now sits 27% of the way up that range. Over the past year the price changed by −34.78%. The P/E ratio is 13.2, which is below the sector median (25.0). Market capitalization is 75.65 million USD, rank 233 among 373 stocks of the same industry with a known capitalization.
Closing prices for 9 October 2026
Next earnings report: 3 November 2026 · Earnings calendar
Change over the period shown (line colour): −33.77 %
Lifevantage Corporation trades on Nasdaq under the ticker LFVN. The company belongs to the Health care sector. The trading history on this page starts on 22 August 2016.
Over the past 52 weeks LFVN has traded between 3.90 $ and 11.71 $. As of 9 October 2026 the price stood 26.89 % of the way from the 52-week low to the high.
Over one year LFVN shares fell 34.78 %; over six months they rose 44.58 %. Volatility over 90 days is 71.25 %. Dividends are not included: this is price change only, as of 9 October 2026.
LFVN trades at a price-to-earnings ratio of 13.2, below the sector median of 25.0. Price to sales is 0.4, below the sector median of 4.0. Price to book is 2.3, below the sector median of 2.5. Calculated from reports for the period ending 31 March 2026.
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 9 October 2026 | 5.93 | 6.08 | 5.93 | 6.00 | 23,200 |
| 8 October 2026 | 6.00 | 6.13 | 5.94 | 5.99 | 32,400 |
| 7 October 2026 | 6.00 | 6.16 | 5.97 | 6.00 | 25,000 |
| 6 October 2026 | 6.03 | 6.16 |
The series is stated in the current share scale after splits; dividends are not included in the price
Based on the last 12 months of reports, through 31 March 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Address:3300 TRIUMPH BLVD SUITE 700, LEHI, UT, 84043, US
Lifevantage Corporation reported revenue of 195M $ and net income of 6M $ over the last four quarters. Net margin is 2.94 %. Revenue changed by −12.15 % year over year. Earnings per share are 0.45 $. Market capitalisation is 76M $.
LFVN has a return on equity of 17.25 %, above the sector median of −41.68 %. Return on assets is 9.26 %, above the sector median of −32.11 %. Operating margin is 3.37 %, above the sector median of −26.84 %.
Lifevantage Corporation pays dividends quarterly: 0.19 $ per share over the past twelve months, a yield of 3.17 %. The latest payment was 0.0500 $, with an ex-dividend date of 1 September 2026. The company has raised its payout for 3 years in a row.
| 1.2B |
| PFEPfizer, Inc. | 28.28 | +1.65 % | 922M |
| ABTAbbott Laboratories | 99.60 | +1.13 % | 921M |
| BMYBristol-Myers Squibb Company | 59.12 | −0.77 % | 714M |
| REGNRegeneron Pharmaceuticals, Inc. | 746.54 | +0.94 % | 555M |
| 5.98 |
| 6.04 |
| 30,100 |
| 5 October 2026 | 6.01 | 6.18 | 5.92 | 6.03 | 27,800 |
| 2 October 2026 | 6.24 | 6.27 | 5.99 | 6.07 | 48,800 |
| 1 October 2026 | 6.31 | 6.40 | 6.12 | 6.24 | 36,100 |
| 30 September 2026 | 6.32 | 6.34 | 6.21 | 6.30 | 18,300 |
| 29 September 2026 | 6.21 | 6.40 | 6.13 | 6.32 | 20,300 |
| 28 September 2026 | 6.26 | 6.36 | 6.17 | 6.19 | 32,200 |
| 25 September 2026 | 6.29 | 6.42 | 6.25 | 6.26 | 10,300 |
| 24 September 2026 | 6.20 | 6.29 | 6.11 | 6.29 | 24,400 |
| 23 September 2026 | 6.12 | 6.20 | 6.00 | 6.20 | 75,900 |
| 22 September 2026 | 6.16 | 6.32 | 6.15 | 6.22 | 38,100 |
| 21 September 2026 | 6.31 | 6.40 | 6.16 | 6.22 | 34,200 |
| 18 September 2026 | 6.31 | 6.54 | 6.14 | 6.35 | 51,000 |
| 17 September 2026 | 6.30 | 6.38 | 6.13 | 6.20 | 22,300 |
| 16 September 2026 | 6.30 | 6.38 | 6.15 | 6.18 | 36,900 |
| 15 September 2026 | 6.25 | 6.32 | 6.13 | 6.18 | 28,400 |
| 14 September 2026 | 6.09 | 6.31 | 6.09 | 6.25 | 41,100 |